Lishengpharma: Company executives plan to reduce their holdings by no more than 11,200 shares of the company

36Kr learned that Lishengpharma announced that the company's senior management personnel, Guo Xiaoyan, plans to reduce holdings of the company's shares by no more than 11,200 shares through centralized bidding, with the planned reduction not exceeding 0.0044% of the total share capital after excluding the number of shares in the repurchase special account